FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/07/070403 [Registered on: 10/07/2024] Trial Registered Prospectively
Last Modified On: 05/07/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   This is a study to compare the outcome of inducing labor by using a tube inserted in cervix along with misoprostol medication either as oral solution or as tablet kept under your tongue among women in their first pregnancy at term gestation requiring induction of labor 
Scientific Title of Study   Comparison of outcome of labor induction by combination of Foleys catheter with either titrated oral misoprostol solution or sublingual misoprostol among nulliparous women at term - A randomized controlled trial 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Lakshanya 
Designation  Junior Resident 
Affiliation  Jawaharlal Institute of Postgraduate Medical Education and Research, Pondicherry 
Address  Department of Obstetrics and Gynecology, Jawaharlal Institute of Postgraduate Medical Education and Research, Dhanvantri Nagar, Gorimedu, Puducherry, India
-
Pondicherry
PONDICHERRY
605006
India 
Phone  9444415274  
Fax  -  
Email  lakshanya123@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Latha Chaturvedula 
Designation  Professor 
Affiliation  Jawaharlal Institute of Postgraduate Medical Education and Research, Pondicherry 
Address  Department of Obstetrics and Gynecology, Jawaharlal Institute of Postgraduate Medical Education and Research, Dhanvantri Nagar, Gorimedu, Puducherry, India
-
Pondicherry
PONDICHERRY
605006
India 
Phone  9486008274  
Fax  -  
Email  jipoghod@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Lakshanya 
Designation  Junior Resident 
Affiliation  Jawaharlal Institute of Postgraduate Medical Education and Research, Pondicherry 
Address  Department of Obstetrics and Gynecology, Jawaharlal Institute of Postgraduate Medical Education and Research, Dhanvantri Nagar, Gorimedu, Puducherry, India
-
Pondicherry
PONDICHERRY
605006
India 
Phone  9444415274  
Fax  -  
Email  lakshanya123@gmail.com  
 
Source of Monetary or Material Support  
Jawaharlal Institute of Postgraduate Medical Education and Research, Dhanvantri Nagar, Gorimedu, Puducherry, India Pincode- 605006 
 
Primary Sponsor  
Name  Jawaharlal Institute of Postgraduate Medical Education and Research 
Address  Jawaharlal Institute of Postgraduate Medical Education and Research, Dhanvantri Nagar, Gorimedu, Puducherry, India 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Lakshanya  Jawaharlal Institute of Postgraduate Medical Education and Research  Labor Ward, Ground Floor, Women and Children’s Hospital, JIPMER, Dhanvantri Nagar, Gorimedu, Puducherry, India, Pincode- 605006
Pondicherry
PONDICHERRY 
9444415274

lakshanya123@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Jawaharlal Institute of Postgraduate Medical Education and Research Puducherry Institutional Ethics Committee- Interventional Studies CDSCO Reg. No. ECR/342/Inst/PY/2013/RR-19  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: O80||Encounter for full-term uncomplicated delivery,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Oral misoprostol solution  22F Foley’s catheter will be introduced intracervically under aseptic precautions such that the bulb of the catheter lies over the internal os. The bulb will be then inflated with 60ml of distilled water. The patient will then be administered the additional induction agent as follows. The first group will receive titrated oral misoprostol solution. The titrated oral misoprostol solution will be prepared by dissolving a 200mcg misoprostol tablet and a 25mcg misoprostol tablet in 225ml of drinking water, to make a solution with concentration of 1mcg/ml, which will be stored at room temperature for a maximum of 24 hours. The solution will be administered as follows: Initial dose of 20mcg hourly for two doses; in the absence of adequate uterine contractions, the dose will be increased to 30 mcg hourly for three doses followed by 40 mcg for one dose, at an interval of 1.5 h, and 50 mcg for one dose. If the first cycle of administration ended with no signs of regular uterine contraction, a second cycle will be started after an interval of 6 h. A maximum of 2 cycles will be given. Further doses will be stopped once the following are observed: regular uterine contractions of 3 in 10 mins lasting more than 40 seconds, fully effaced or dilation of the cervix more than or equal to 4.0 cm.  
Comparator Agent  Sublingual misoprostol  22F Foley’s catheter will be introduced intracervically under aseptic precautions such that the bulb of the catheter lies over the internal os. The bulb will be then inflated with 60ml of distilled water. The second group will be given sublingual misoprostol 25 mcg at intervals of 4 hours for a maximum of 6 doses. Further doses will be stopped once the following are observed: regular uterine contractions of 3 in 10 mins lasting more than 40 seconds, fully effaced or dilation of the cervix more than or equal to 4.0 cm. 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  50.00 Year(s)
Gender  Female 
Details  1)Nulliparous women ≥ 18 years of age
2)Gestational age ≥ 37 weeks
3)Singleton pregnancy, vertex presentation
4)Bishop’s score less than or equal to 4
 
 
ExclusionCriteria 
Details  1)Women with severe pre-eclampsia
2)Premature rupture of membranes
3)Previously scarred uterus (myomectomy/ septal resection)
4)Previous anaphylaxis to prostaglandins
5)Abnormal FHR changes
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Proportion of successful vaginal delivery  72 hours after insertion of foleys catheter 
 
Secondary Outcome  
Outcome  TimePoints 
Time from induction to delivery   72 hours after insertion of foleys catheter 
Maternal & fetal outcome  72 hours after insertion of foleys catheter 
 
Target Sample Size   Total Sample Size="304"
Sample Size from India="304" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2/ Phase 3 
Date of First Enrollment (India)   25/07/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="2"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - YES
  1. What data in particular will be shared?
    Response - Individual participant data that underlie the results reported in this article, after de-identification (text, tables, figures, and appendices).

  2. What additional supporting information will be shared?
    Response -  Study Protocol
    Response -  Statistical Analysis Plan
    Response - Informed Consent Form
    Response - Clinical Study Report

  3. Who will be able to view these files?
    Response - Researchers whose proposed use of the data has been approved by an independent review committee identified for this purpose.

  4. For what types of analyses will this data be available?
    Response - To achieve aims in the approved proposal.

  5. By what mechanism will data be made available?
    Response - Proposals should be directed to [lakshanya123@gmail.com].

  6. For how long will this data be available start date provided 15-07-2026 and end date provided 15-07-2029?
    Response - Beginning 9 months and ending 36 months following article publication.

  7. Any URL or additional information regarding plan/policy for sharing IPD? 
    Additional Information - NIL
Brief Summary  

This is a randomised controlled trial to compare the outcome of induction of labor by intracervical Foley’s catheter with titrated oral misoprostol solution versus intracervical Foley’s catheter with sublingual misoprostol in nulliparous women at term. this study will be conducted for 18 months in a tertiary centre in South India. 152 women in one group will receive titrated misoprostol solution after insertion of intracervical Foley’s catheter, while 152 women in the other group will receive sublingual misoprostol after insertion of intracervical Foley’s catheter. The primary outcome is measured by the proportion of successful vaginal deliveries. the secondary outcomes observed will be the difference in the time from induction to delivery and incidence of any maternal or fetal adverse effects.


 
Close